Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy
Page 1 of 1
Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy
Jon Moulton Mon Apr 28, 2014 2:37 pm
Waugh TA, Horstick E, Hur J, Jackson SW, Davidson AE, Li X, Dowling JJ. Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy. Hum Mol Genet. 2014 Apr 23. [Epub ahead of print]
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Implications for Cardiac Function Following Rescue of the Dystrophic Diaphragm in a Mouse Model of Duchenne Muscular Dystrophy
» Drug screening in a zebrafish model of Duchenne muscular dystrophy
» The HDAC Inhibitor TSA Ameliorates a Zebrafish Model of Duchenne Muscular Dystrophy
» Epigenetic Regulators Modulate Muscle Damage in Duchenne Muscular Dystrophy Model
» Enhanced exon skipping in the 4CV dystrophic mouse model of muscular dystrophy through refined oligomer design
» Drug screening in a zebrafish model of Duchenne muscular dystrophy
» The HDAC Inhibitor TSA Ameliorates a Zebrafish Model of Duchenne Muscular Dystrophy
» Epigenetic Regulators Modulate Muscle Damage in Duchenne Muscular Dystrophy Model
» Enhanced exon skipping in the 4CV dystrophic mouse model of muscular dystrophy through refined oligomer design
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum|
|
|